ESAB Corporation (ESAB) Balance Sheet

The balance sheet has expanded rapidly, with total assets jumping from $4.0B in 2024Q2 to $6.6B in 2026Q2, largely reflecting the $1.5B acquisition outflow noted in cash flow data. This growth is primarily acquisition-driven rather than organic, as evidenced by the corresponding increase in goodwill from $1.6B to $2.7B. The equity base has also grown, but at a slower pace than assets, indicating that leverage is being used to fund expansion, which may signal a strategic shift toward a more acquisitive growth model.

The D/E ratio has risen from 0.65 in 2025Q4 to 0.94 in 2026Q2, reflecting the $1.5B acquisition funded partly by debt. While still below the 2.78 D/E of peer ITW, the rapid increase suggests a strategic use of leverage to finance growth, but it also raises refinancing risk if cash flows falter. The absolute debt level of $2.4B is substantial relative to equity of $2.5B, and investors should monitor whether the acquired assets generate sufficient returns to service this debt.

The asset mix is increasingly dominated by goodwill, which rose from $1.6B in 2024Q1 to $2.7B in 2026Q2, reflecting the GCE and Ohio Medical acquisitions. This raises impairment risk if the acquired businesses underperform, especially given the integration challenges typical of bolt-on M&A. PPE remains modest at $533M, indicating an asset-light model, but the heavy reliance on intangibles suggests that the company's value is tied to the performance of acquired brands and technology.

Equity has expanded from $1.6B in 2024Q1 to $2.5B in 2026Q2, with retained earnings contributing significantly, rising from $406.9M to $865.8M. This suggests that the company is retaining profits to fund growth, though the pace of retained earnings growth (79% YoY) is slower than asset growth (65% YoY), implying that debt is also financing expansion. No share repurchases were noted in the cash flow data, indicating a preference for reinvestment over returning capital to shareholders.

The current ratio has remained above 1.8 over the past year, reaching 1.96 in 2026Q2, indicating a solid liquidity position. However, cash levels are volatile, swinging from $1.0B in 2026Q1 to $217.5M in 2026Q2, likely due to the acquisition outflow. This suggests that while the company maintains adequate short-term coverage, its cash buffer can be quickly deployed for strategic purposes, which may leave it more exposed to unexpected shocks.